U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS
This repository is under review for potential modification in compliance with Administration directives.

Details

Stereochemistry RACEMIC
Molecular Formula C12H20N2O3
Molecular Weight 240.2988
Optical Activity ( + / - )
Defined Stereocenters 0 / 1
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of Tetrabarbital

SMILES

CCCC(CC)C1(CC)C(=O)NC(=O)NC1=O

InChI

InChIKey=ZLUNGGZJSQDFPH-UHFFFAOYSA-N
InChI=1S/C12H20N2O3/c1-4-7-8(5-2)12(6-3)9(15)13-11(17)14-10(12)16/h8H,4-7H2,1-3H3,(H2,13,14,15,16,17)

HIDE SMILES / InChI
Molecular Formula C12H20N2O3
Molecular Weight 240.2988
Charge 0
Count
MOL RATIO 1 MOL RATIO (average)
Stereochemistry RACEMIC
Additional Stereochemistry No
Defined Stereocenters 0 / 1
E/Z Centers 0
Optical Activity ( + / - )

Description

Tetrabarbital is a barbituric acid derivative patented by Eli Lilly and Co. as a central nervous system depressant. In chloralosed dogs, intravenous Tetrabarbital 2.5-10 mg/kg, accelerated the heartbeat and lowered the carotid pressure.

Originator

Eli Lilly and Co.
6

Approval Year

Unknown
145,056

PubMed

Patents

1985217
1
Substance Class Chemical
Record UNII
3K441526FO
Record Status Validated (UNII)
Record Version
NIH
NCATS
PRIVACY ACT
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966